Unknown

Dataset Information

Extended time frame for restoring inner ear function through gene therapy in Usher1G preclinical model.


ABSTRACT: Neonatal gene therapy has been shown to prevent inner ear dysfunction in mouse models of Usher syndrome type I (USH1), the most common genetic cause of combined deafness-blindness and vestibular dysfunction. However, hearing onset occurs after birth in mice and in utero in humans, making it questionable how to transpose murine gene therapy outcomes to clinical settings. Here, we sought to extend the therapeutic time window in a mouse model for USH1G to periods corresponding to human neonatal stages, more suitable for intervention in patients. Mice with deletion of Ush1g (Ush1g-/-) were subjected to gene therapy after the hearing onset. The rescue of inner ear hair cell structure was evaluated by confocal imaging and electron microscopy. Hearing and vestibular function were assessed by reco

SUBMITTER: Lahlou G 

PROVIDER: S-EPMC10967394 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature